Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor-Reference-Cited by-同舟云学术

Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor

Published:1997-02 Issue:2 Volume:6 Page:199-208
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Ikeda Hideyuki,Lethé Bernard,Lehmann Frédéric,Van Baren Nicolas,Baurain Jean-François,De Smet Charles,Chambost Hervé,Vitale Massimo,Moretta Alessandro,Boon Thierry,Coulie Pierre G

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference60 articles.

1. Peptide synthesis;Atherton;II. Procedures for solid-phase synthesis using Nα-fluorenylmethysoxycarbamylamino acid on polymide supports,1981

2. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules;Biassoni;J. Exp. Med,1995

3. BAGE;Boël;Immunity,1995

4. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation;Bottino;Eur. J. Immunol., in press,1996

5. A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma;Brändle;J. Exp. Med,1996

Cited by 662 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digital quantification of PRAME for distinguishing melanoma from nevi compared to manual assessment;Pathology - Research and Practice;2024-10

2. Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding;Journal of Biological Chemistry;2024-09

3. Utility of PRAME Immunohistochemistry in the Detection of Subtle Melanoma Microsatellites;The American Journal of Dermatopathology;2024-08-14

4. High Resolution HLA-A, HLA-B, and HLA-C Allele Frequencies in Romanian Hematopoietic Stem Cell Donors;International Journal of Molecular Sciences;2024-08-14

5. Next-generation cancer vaccines and emerging immunotherapy combinations;Trends in Cancer;2024-08